Unipath launches unisex chlamydia test:
This article was originally published in Clinica
Executive Summary
Unipath has introduced Clearview Chlamydia MF, a chlamydia test that is suitable for both male and female patients and can provide a result during a patient's visit. For male patients, a first-pass urine sample is diluted and centrifuged and chlamydial antigen extracted from the resulting pellet with a short heat extraction step. For female patients, an endocervical swab specimen is heat extracted. In either case, addition of the extract to the test unit gives results within 15 minutes. The company claims the test has high specificity and sensitivity.